Silencing the expression of Epac1, Raptor and Rictor by RNAi profoundly attenuated the activation of these signaling cascades in prostate cancer cells treated with 8-CPT-2Me-cAMP [47], [48]. This evidence concerns the gene RAPGEF3 and Familial prostate cancer.